ProMIS Neurosciences Institutional ownership
What is the Institutional ownership of ProMIS Neurosciences?
The Institutional ownership of ProMIS Neurosciences, Inc. is 1.17%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on TSX compared to ProMIS Neurosciences
What does ProMIS Neurosciences do?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Companies with institutional ownership similar to ProMIS Neurosciences
- EnWave has Institutional ownership of 1.16%
- MacDonald Mines Exploration has Institutional ownership of 1.16%
- CBL & Associates Properties has Institutional ownership of 1.16%
- Keyrus SA has Institutional ownership of 1.16%
- Sunstone Metals has Institutional ownership of 1.16%
- Oconee Federal Corp has Institutional ownership of 1.16%
- ProMIS Neurosciences has Institutional ownership of 1.17%
- James Hardie Industries plc has Institutional ownership of 1.17%
- Malaga has Institutional ownership of 1.17%
- Prime Securities has Institutional ownership of 1.17%
- Voith Paper Fabrics India has Institutional ownership of 1.17%
- Overactive Media Corp has Institutional ownership of 1.17%
- ENM has Institutional ownership of 1.18%